C
Amneal Pharmaceuticals, Inc. AMRX
$4.66 $0.358.12%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Revenue 620.04M 599.05M 557.54M 609.76M 545.56M
Total Other Revenue -- -- -- -- --
Total Revenue 620.04M 599.05M 557.54M 609.76M 545.56M
Cost of Revenue 388.40M 379.85M 370.00M 390.41M 352.04M
Gross Profit 231.65M 219.20M 187.54M 219.35M 193.52M
SG&A Expenses 113.01M 105.57M 102.10M 102.16M 100.07M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses 73.00K 13.00K -1.22M -1.47M -1.32M
Total Operating Expenses 542.85M 523.23M 509.56M 533.01M 501.02M
Operating Income 77.19M 75.82M 47.98M 76.75M 44.53M
Income Before Tax 22.96M 29.66M -9.43M -7.66M 2.18M
Income Tax Expenses -2.08M -23.00K 668.00K -1.80M 4.57M
Earnings from Continuing Operations 25.03M 29.68M -10.09M -5.86M -2.39M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -15.35M -17.77M 3.15M 1.53M -299.00K
Net Income 9.68M 11.92M -6.94M -4.33M -2.69M
EBIT 77.19M 75.82M 47.98M 76.75M 44.53M
EBITDA 134.40M 132.93M 106.13M 137.81M 106.14M
EPS Basic 0.06 0.08 -0.05 -0.03 -0.02
Normalized Basic EPS 0.00 -0.01 0.04 0.15 0.01
EPS Diluted 0.06 0.08 -0.05 -0.03 -0.02
Normalized Diluted EPS 0.00 -0.01 0.04 0.15 0.01
Average Basic Shares Outstanding 154.22M 153.74M 152.11M 151.48M 151.39M
Average Diluted Shares Outstanding 159.69M 154.89M 152.11M 151.48M 151.39M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings